<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The plasma concentration of the platelet-specific protein beta-thromboglobulin (beta-TG) was measured in 39 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and 568 patients of <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The beta-TG RIA commercially available KIT was also evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>Abnormally high plasma levels of beta-TG were demonstrated in groups of ischemic or obstructive cerebrovascular diseases as compared with that of <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>The highest concentrations were found in 8 patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moya-Moya disease</z:e>, (mean concentration of beta-TG was 204.4 ng/ml), completed <z:hpo ids='HP_0001297'>stroke</z:hpo> at an <z:hpo ids='HP_0011009'>acute</z:hpo> stage was next (mean beta-TG level was 194.8 +/- 70.8 ng/ml) </plain></SENT>
<SENT sid="4" pm="."><plain>On the other hand, many hemorrhagic cerebro-<z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> or other <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> such as <z:mp ids='MP_0009277'>brain tumors</z:mp>, <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo>, etc. do not show elevated beta-TG levels </plain></SENT>
<SENT sid="5" pm="."><plain>In many patients with ischemic or obstructive cerebro-<z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> treated with anti-platelet drugs such as Aspirin, <z:chebi fb="0" ids="4653">Dipyridamole</z:chebi>, Bencyclane or <z:chebi fb="0" ids="9588">Ticlopidine</z:chebi>, a significant fall in plasma concentration of beta-TG was chronologically demonstrated </plain></SENT>
<SENT sid="6" pm="."><plain>The measurement of plasma beta-TG concentration may be useful not only in the diagnosis of ischemic or obstructive cerebro-<z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disorders</z:e> but also in judging the efficacy of anti-platelet therapies and prognosis </plain></SENT>
</text></document>